Predicting and preventing clonal evolution in multiple myeloma
What leads to shorter progression-free survival in CLL patients?
Key therapeutic advances in follicular lymphoma
Venetoclax and ibrutinib and drug combinations for CLL
An overview of the lymphoma landscape from BSH 2017